We are excited to introduce NewCrop Rx v2!
Our development team has been collaborating closely with our ePrescribing vendor to bring you the latest version of NewCrop Rx. The new platform is designed to enhance usability and reliability, offering a host of new features including:
- A fresh, modern, and intuitive interface.
- Real-time benefits information (including alternative drug options).
- Customized SIG builders.
- New drop-down menus and much more!
To ensure a seamless transition, please review the Migration Guide prior to your transition.
To assist you in mastering the ePrescribing process and optimizing your transition experience, the following resources are also available:
The ePrescribing process within EyeMD EMR remains unchanged and the close integration between both systems continues to seamlessly share information.
Once you have reviewed the updates and are ready to proceed, please contact our Customer Service team at cs@eyemdemr.com to schedule your transition.
IMPORTANT DEADLINE: Please plan on transitioning by July 31, 2024, as availability to NewCrop Rx v1 will cease on August 30, 2024. All remaining practices will be automatically transitioned August 16th, 2024.
EyeMD EMR v1.x is no longer maintained and does not support NewCrop Rx v2. Since access to NewCrop Rx v1 will cease on August 30, 2024, EyeMD EMR v1.x users will need to upgrade to EyeMD EMR v2.x to maintain e-Rx access.